The relationship between infant and parent Lp(a) levels

Area of Science:

• Cardiovascular Science
• Genetics
• Pediatric Endocrinology

Background:

• Atherogenesis, the development of arterial plaques, can start in childhood.
• Elevated serum lipoprotein(a) (Lp(a)) levels are a known risk factor for cardiovascular disease.
• Understanding early apolipoprotein(a) (apo(a)) gene expression is crucial for early risk assessment.

Purpose of the Study:

• To investigate the early expression of the apolipoprotein(a) (apo(a)) gene in newborns.
• To examine the relationship between infant and parental serum lipoprotein(a) (Lp(a)) levels.
• To assess the predictive value of early Lp(a) measurements for identifying cardiovascular risk in families.

Main Methods:

• Analysis of apolipoprotein(a) (apo(a)) levels in 1032 newborns (3-5 days old).
• Re-measurement of Lp(a) concentrations in 51 infants at 8.5 months, along with parental samples.
• Statistical correlation and regression analyses to determine relationships between infant and parental Lp(a) levels.

Main Results:

• Infant apo(a) levels at 3-5 days showed a skewed distribution, similar to adults but lower.
• Infant Lp(a) levels at 8.5 months were highly correlated with levels at 3-5 days (r=0.73) and increased twofold.
• Infant Lp(a) levels at 8.5 months closely mirrored parental levels, with strong predictive values for parental Lp(a) >300 mg/l.

Conclusions:

• The apo(a) gene is nearly fully expressed within the first year of life.
• Infant Lp(a) levels track closely and predict parental values, indicating early genetic influence.
• Childhood Lp(a) screening can identify families with heightened cardiovascular risk for targeted prevention strategies.